Delivery Order SPE2DR25D3304-SPE2DR26F47Q2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.02 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed price, non-set-aside delivery order was awarded on November 17, 2025, with an ultimate completion date of December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,147.67 to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine doses (0.5mL syringes for ages 12 and up) with a firm fixed price structure. The award, issued on June 4, 2025, with completion targeted for June 26, 2025, represents a non-set-aside, competitively awarded contract. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.50 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order was issued on November 5, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine vaccine procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,975.10 to AmerisourceBergen Drug Corp for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. The award was made on November 17, 2025, with an ultimate completion date of December 9, 2025, under a firm fixed-price contract type with no set-aside designation. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,087.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5 mL syringes, with an ultimate completion date of November 20, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.22 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (12 years and older), 0.5 milliliter syringes, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F47Q2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) with a ceiling value of $1,792.50. The contract, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability in competitively awarded medical supply delivery, including vaccines, specialty medications, and medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/18/25 |